Tekoälypäivä 2027 · pe 12.3. · Oodi, HelsinkiTekoälypäivä 2027 · 12.3.Lue lisää

About

A physician-led Finnish medical AI company

AiXiliator Oy is a Finnish medical AI advisory and development company founded by three active physicians and researchers. We help organizations develop, validate, implement and bring medical AI solutions toward the European market, and intend over time to also serve as the formal manufacturer for selected medical AI products.

Why the company was founded

Successful medical AI requires more than clinical expertise, more than technology and more than research. The company was created to bring these perspectives together: promising technology often fails to reach patients because clinical need, evidence, regulation, implementation and commercialization are not addressed as one integrated process.

Our work is grounded in current clinical practice. All three founders remain active physicians, bringing direct understanding of clinical workflows, decision-making and the practical realities of healthcare.

The founding team has been involved in medical AI since the early 2010s, spanning clinical problem definition, algorithm development, validation and clinical evaluation.

Medical AI ultimately needs evidence. Our founders have extensive experience in clinical research, from study design and ethics processes to clinical trials, multicentre studies, validation and real-world evidence. This allows us to assess not only whether an AI solution can be built, but how it should be evaluated in real clinical practice.

Clinical and technical expertise alone are not enough. Successful implementation also requires an understanding of how healthcare organizations make decisions, procure technology and integrate new solutions into clinical practice. Across the team, we have worked in public and private healthcare, hospital administration and clinical leadership, and with pharmaceutical and technology partners.

Now

Consulting and advisory

Clinical need assessment, value assessment, intended purpose, evidence strategy, European regulatory strategy, quality-management planning, market access, healthcare AI strategy and implementation, and expert speaking.

Next

Building a pathway to formal manufacturing

AiXiliator intends to serve as the formal manufacturer for selected medical AI products in Europe, and is developing the quality, regulatory and organizational capabilities required for this role.

How we work

Principles we apply in every engagement

Patient safety first

If a product is not ready for use with patients, our advice will say so.

Evidence before claims

Clear statements of intended use, known limitations, required oversight and monitoring, and claims that stay within the evidence.

Clinical experts throughout

All three founders remain active in clinical practice, so products are defined around real clinical workflows and decision-making.

Long-term partnership

We prefer a small number of multi-year client relationships to short advisory assignments.

AiXiliator Oy currently provides consulting and advisory services on medical AI development, clinical evidence, regulation, implementation and market access. The formal manufacturer role is a strategic direction under development. We are not a notified body, certification organisation or regulatory authority, we do not issue CE certificates or approvals, and we do not speak on behalf of notified bodies or authorities.